In an asymptomatic 30-year-old male with normal blood urea nitrogen and creatinine and a single urinalysis showing 6–8 red blood cells per high-power field, what is the appropriate management?

Management of Single Urinalysis Finding of 6-8 RBC/hpf in Asymptomatic 30-Year-Old Male

Repeat the urinalysis before initiating any further workup—a single finding of 6-8 RBC/hpf does not meet the threshold for full urologic evaluation in this low-risk patient.

Initial Step: Confirm the Hematuria

The most critical first step is microscopic confirmation on repeat urinalysis. Current guidelines require ≥3 RBC/hpf on microscopic examination to define microhematuria, but importantly, the 2012 AUA guideline originally recommended confirmation on at least 2 of 3 properly collected specimens before proceeding with evaluation 1. While the updated 2020 ACR criteria note that a single positive result may warrant evaluation 2, this applies primarily to higher-risk patients. The 2016 ACP High-Value Care advice explicitly states that clinicians should confirm heme-positive results with microscopic urinalysis demonstrating ≥3 RBC/hpf before initiating further evaluation 3.

Key Actions:

• Obtain 2 additional properly collected, clean-catch, midstream urine specimens
• Ensure specimens are fresh and examined microscopically (not just dipstick)
• Rule out contamination from recent vigorous exercise, sexual activity, or trauma
• Exclude urinary tract infection with urine culture if any signs of infection present

Risk Stratification for This Patient

This 30-year-old male falls into the low/negligible risk category based on the 2025 AUA/SUFU risk stratification system 4:

Low/Negligible Risk Criteria (ALL must be met):

• Age <40 years ✓
• 3-10 RBC/HPF (his 6-8 RBC/hpf qualifies) ✓
• Never smoker or <10 pack-years (need to confirm)
• No additional risk factors for urothelial cancer ✓

The risk of malignancy in this category is 0%-0.4% 4. The 2020 ACR guideline confirms that patients with microhematuria have a low malignancy risk of only 2.6%-4%, and most asymptomatic microhematuria cases never identify a cause 2.

If Hematuria Persists on Repeat Testing

Exclude Benign Causes First:

Before proceeding to imaging or cystoscopy, specifically assess for 2:

• Recent vigorous exercise (resolve within 48-72 hours of cessation)
• Recent urologic procedures
• Urinary tract infection (treat and repeat UA 6 weeks post-treatment)
• Trauma history

Evaluate for Glomerular Disease:

Check for indicators of renal parenchymal disease 1, 5:

• Proteinuria on urinalysis
• Dysmorphic RBCs or RBC casts on microscopy
• Elevated serum creatinine (though normal in this case)
• Hypertension on physical exam

If any glomerular indicators are present: Refer to nephrology rather than urology 1, 5.

Full Urologic Evaluation (Only if Hematuria Confirmed AND Persistent)

Given his age <35 years and low-risk profile, the approach differs from older patients. However, if microhematuria persists on repeat testing without benign cause:

Imaging:

• CT urography (multiphasic) is the preferred imaging modality for upper tract evaluation 2, 1, 2
• Alternative: Renal ultrasound is reasonable in this young, low-risk patient to minimize radiation exposure 2

Cystoscopy:

The 2012 AUA guideline recommends cystoscopy for all patients ≥35 years 1. At age 30, cystoscopy may be deferred unless:

• He has risk factors (smoking >10 pack-years, occupational chemical exposure, chronic UTIs, pelvic irradiation history)
• Irritative voiding symptoms are present
• Hematuria persists or worsens on follow-up

The 2016 ACP guideline supports considering urology referral for cystoscopy in adults with confirmed hematuria absent a benign cause 3, but emphasizes this is a consideration rather than automatic requirement in low-risk patients.

Do NOT Order:

• Urinary cytology is not recommended in the initial evaluation of asymptomatic microhematuria in low-risk patients 3
• Screening urinalysis should not be used for cancer detection 3

Common Pitfalls to Avoid

1. Acting on a single urinalysis: The intermittent nature of hematuria means a single finding may not be clinically significant, especially in young, low-risk patients
2. Ordering full workup without confirming microscopic hematuria: Dipstick alone is insufficient 3
3. Ignoring transient causes: Always ask about recent exercise, sexual activity, or minor trauma before proceeding
4. Missing glomerular disease indicators: Check for proteinuria, casts, and dysmorphic RBCs to avoid inappropriate urology referral when nephrology is needed

Follow-Up Strategy

If repeat urinalyses are negative or show <3 RBC/hpf:

• No further workup needed
• Consider annual urinalysis monitoring if patient has anxiety about the finding

If microhematuria persists but evaluation is negative:

• Annual urinalysis for surveillance 1
• Repeat anatomic evaluation within 3-5 years if hematuria persists 1
• Monitor for development of risk factors (smoking, occupational exposures)

The key principle is that transient or isolated microhematuria in a young, asymptomatic male without risk factors does not automatically warrant invasive evaluation—confirmation and risk stratification guide the appropriate level of investigation.